Eltrombopag-Associated Cerebral Venous Thrombosis
- 1 January 2021
- journal article
- letter
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of Sport Medicine
- Vol. 28 (1), e167-e169
- https://doi.org/10.1097/mjt.0000000000001044
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonistsRheumatology, 2018
- Cerebral venous thrombosis in refractory idiopathic thrombocytopenia treated with eltrombopagAnnals of Indian Academy of Neurology, 2016
- Signal for Thrombosis with Eltrombopag and Romiplostim: A Disproportionality Analysis of Spontaneous Reports Within VigiBase®Drug Safety, 2015
- Extensive cerebral venous sinus thrombosis following a dose increase in eltrombopag in a patient with idiopathic thrombocytopenic purpuraPlatelets, 2013